Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Melatonin administration in insomnia.

S P James1, D A Sack, N E Rosenthal

  • 1Hospital of the University of Pennsylvania, Philadelphia 19104.

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|February 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cholera rapid diagnostic tests at the host-microbe interface: Key Considerations for Global Deployments.

medRxiv : the preprint server for health sciences·2025
Same author

Gold Standard Cholera Diagnostics Are Tarnished by Lytic Bacteriophage and Antibiotics.

Journal of clinical microbiology·2020
Same author

Treating depression with botulinum toxin: a pooled analysis of randomized controlled trials.

Pharmacopsychiatry·2015
Same author

Toxins and virulence factors of enterotoxigenic Escherichia coli associated with strains isolated from indigenous children and international visitors to a rural community in Guatemala.

Epidemiology and infection·2014
Same author

A patient who changed my practice: Herb Kern, the first light therapy patient.

International journal of psychiatry in clinical practice·2014
Same author

A novel and simple mixture as point-of-use water treatment agent to produce safe drinking water.

Transactions of the Royal Society of Tropical Medicine and Hygiene·2014
Same journal

CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorder.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same journal

In memoriam: Jon Kar Zubieta, M.D., Ph.D.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same journal

Pharmacokinetics and concentration-behavioral effect relationships differ between brain subcompartments.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same journal

Auditory event-related potentials and psychosis dimensions.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same journal

Cultural humility in the teaching and practice of clinical care.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same journal

Kappa opioid receptors mediate aversion-and it matters.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
See all related articles

Melatonin did not alter sleep onset or duration in patients with persistent insomnia. While patients perceived less sleep, subjective sleep quality improved, with a notable increase in REM latency at a 1-mg dose.

Area of Science:

  • Neuroscience
  • Sleep Medicine
  • Pharmacology

Background:

  • Persistent insomnia affects a significant portion of the population, impacting overall health and well-being.
  • Melatonin, a hormone regulating sleep-wake cycles, is often explored for insomnia treatment.
  • Understanding melatonin's precise effects on sleep architecture is crucial for clinical application.

Purpose of the Study:

  • To investigate the effects of two oral melatonin dosages (1 mg and 5 mg) on electroencephalogram (EEG)-recorded sleep in patients with persistent insomnia.
  • To assess the impact of melatonin on sleep onset, duration, rapid-eye-movement (REM) sleep parameters, and next-day mood and alertness.

Main Methods:

  • A double-blind, randomized study design was employed with ten patients diagnosed with persistent insomnia.

Related Experiment Videos

  • Participants received either 1 mg or 5 mg of oral melatonin.
  • Sleep was monitored using electroencephalogram (EEG) recordings, and subjective measures of sleep quality, mood, and alertness were collected.

    • Main Results:

    • No significant changes were observed in sleep onset or sleep duration with either melatonin dosage.
    • A significant increase in REM latency was observed specifically at the 1-mg melatonin dose; other REM sleep parameters remained unaffected.
    • Patients reported a subjective decrease in sleep duration but an overall improvement in subjective sleep quality.

    Conclusions:

    • Oral melatonin, at 1 mg and 5 mg, did not objectively alter sleep onset or duration in patients with persistent insomnia.
    • The 1-mg dose of melatonin may influence REM sleep initiation by increasing REM latency.
    • Despite a perception of reduced sleep, patients experienced improved subjective sleep quality, suggesting a potential therapeutic benefit that warrants further investigation.